mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.007 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.009 |